Challenges in pediatric drug development: A pharmaceutical industry perspective

Pediatric Drugs

Volumn 11, Issue 1, 2009, Pages 57-59

  Rose, Klaus ^a  

^a Roche   (Switzerland)

Author keywords

Children; Pharmaceutical industry; Pharmacology; Research and development

Indexed keywords

CHILD HEALTH CARE; CLINICAL RESEARCH; CONFERENCE PAPER; DEVELOPING COUNTRY; DRUG INDUSTRY; DRUG RESEARCH; EUROPEAN UNION; HEALTH CARE POLICY; MEDICAL CARE; PRIORITY JOURNAL; UNITED STATES; WORLD HEALTH ORGANIZATION;

CHEMISTRY, PHARMACEUTICAL; CHILD; DRUG APPROVAL; DRUG DESIGN; DRUG INDUSTRY; HUMANS; LEGISLATION, DRUG; PEDIATRICS; PHARMACOLOGY, CLINICAL; TECHNOLOGY, PHARMACEUTICAL;

EID: 58149335139     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/0148581-200911010-00019     Document Type: Conference Paper

References (8)

1. Rose K. Ethical, regulatory and scientific challenges in paediatric drug development. Pharm Med 2008; 22 (4): 221-34
2. Rose K, van den Anker J. Guide to paediatric clinical research. Basel: Karger Publishers, 2007
3. WHO. Essential medicines for children [online]. Available from URL: http://www.who.int/childmedicines/en/index.html [Accessed 2008 Oct 3]
4. PhRMA [online]. Available from URL: http://www.phrma.org [Accessed 2008 Nov 10]
5. The European Federation of Pharmaceutical Industries and Associations (EFPIA) [online]. Available from URL: http://www.efpia.org [Accessed 2008 Nov 10]
6. International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) [online]. Available from URL: http://www.ifpma.org [Accessed 2008 Nov 10]
7. Medicines for Malaria Venture (MMV) [online]. Available from URL: http://www.mmv.org [Accessed 2008 Nov 10]
8. Drugs for Neglected Diseases initiative (DENDi) [online]. Available from URL: http://www.dndi.org [Accessed 2008 Nov 10]